logo-loader
OTCMKTS:KALTF

Kalytera Therapeutics Inc.

Receive alerts
Market:
OTCQB
Market Cap:
$8.51 m
Price
0.02 USD
Change
-5.71%
52 weeks high
0.25
52 weeks low
0.00

In brief

Kalytera Therapeutics Inc (TSX-V: KALY, OTCQB: KALTF) is a clinical-stage specialty pharmaceutical company, develops cannabinoid medicines for a range of unmet medical needs. It is developing cannabidiol formulations to prevent and treat acute graft versus host diseases.